Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal fentanyl vs intranasal ketamine for sedation in phacoemulsification
IRCT20170809035601N11Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fentanyl and ketamine in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Sedative effect comparison. Started Jul 2019; status: completed.
02
Drugs
fentanylketamine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20170809035601N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170809035601N11.